This presentation will be focusing on the diagnostics and treatment of Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA) vasculitis in regard to the 2021 American College of Rheumatology and European Alliance of Associations for Rheumatology guideline updates.

Recording: Pharmacist CPE_Read The Rheum- A Review of ANCA Vasculitis Treament-Meeting Recording.mp4

Speaker(s):   Beau Blake, PharmD, PGY2 Critical Care Pharmacy Resident – Aurora Health Care Metro, Inc.​

Objectives: ​​

  1. Identify the Pathophysiology of Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA) Vasculitis and Three Affected Organ Systems
  2. Differentiate Between the Main Diagnostic Features of Severe Versus Non-Severe ANCA Vasculitis
  3. Develop an Individualized Medication Treatment Plan for Patients with ANCA Vasculitis Based on Guideline and Trial Recommended Induction Versus Remission Therapy
  4. Identify at Least One Benefit and One Monitoring Parameter for Each Drug Class Used to Treat ANCA Vasculitis
 
Target Audience:​ Advocate Pharmacists
 
Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. 
Session date: 
02/02/2024 - 1:00pm to 2:00pm CST
Location: 
ASLMC Stiemke Auditorium & Virtual Via Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Please login or register to take this course.